| Periostin is a novel therapeutic target that predicts and regulates glioma malignancy AM Mikheev, SA Mikheeva, AD Trister, MJ Tokita, SN Emerson, ... Neuro-oncology 17 (3), 372-382, 2015 | 76 | 2015 |
| Somatic PDGFRB activating variants in fusiform cerebral aneurysms Y Karasozen, JW Osbun, CA Parada, T Busald, P Tatman, ... The American Journal of Human Genetics 104 (5), 968-976, 2019 | 31 | 2019 |
| Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression CA Parada, J Osbun, S Kaur, Y Yakkioui, M Shi, C Pan, T Busald, ... Scientific reports 8 (1), 2098, 2018 | 30 | 2018 |
| Autolytic Mycobacterium leprae Hsp65 fragments may act as biological markers for autoimmune diseases CA Parada, F Portaro, EB Marengo, CF Klitzke, EJ Vicente, M Faria, ... Microbial pathogenesis 51 (4), 268-276, 2011 | 11 | 2011 |
| Phosphoproteomic and kinomic signature of clinically aggressive grade i (1.5) meningiomas reveals RB1 signaling as a novel mediator and biomarker CA Parada, JW Osbun, T Busald, Y Karasozen, S Kaur, M Shi, J Barber, ... Clinical Cancer Research 26 (1), 193-205, 2020 | 9 | 2020 |
| Comparative proteomic profiling using two-dimensional gel electrophoresis and identification via LC-MS/MS reveals novel protein biomarkers to identify aggressive subtypes of … JW Osbun, PD Tatman, S Kaur, C Parada, T Busald, L Gonzalez-Cuyar, ... Journal of Neurological Surgery Part B: Skull Base 78 (05), 371-379, 2017 | 7 | 2017 |
